Report from the International Union Against Cancer (UICC) Tumor Biology Committee: UICC workshop on the use of dendritic cells in cancer clinical trials (Q73265616)

From Wikidata

Jump to navigation Jump to search

scientific article published on 01 December 1999

Language	Label	Description	Also known as
English	Report from the International Union Against Cancer (UICC) Tumor Biology Committee: UICC workshop on the use of dendritic cells in cancer clinical trials	scientific article published on 01 December 1999

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Report from the International Union Against Cancer (UICC) Tumor Biology Committee: UICC workshop on the use of dendritic cells in cancer clinical trials (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

based on heuristic

inferred from title

Martin Thurnher

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

M L Salgaller

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G Bartsch

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

A L Boynton

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

G P Murphy

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

language of work or name

0 references

publication date

1 December 1999

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

86

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

12

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

2674-2683

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Induction of primary carcinoembryonic antigen (CEA)-specific cytotoxic T lymphocytes in vitro using human dendritic cells transfected with RNA.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Induction of primary, human antigen-specific cytotoxic T lymphocytes in vitro using dendritic cells pulsed with peptides

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Dendritic cell-based approaches to cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Use of cellular and cytokine adjuvants in the immunotherapy of cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Transfer of antigen between dendritic cells in the stimulation of primary T cell proliferation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Response criteria for the prostate of the USA national prostatic cancer project

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

In vitro propagated dendritic cells from prostate cancer patients as a component of prostate cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Phase I clinical trial: T-cell therapy for prostate cancer using autologous dendritic cells pulsed with HLA-A0201-specific peptides from prostate-specific membrane antigen

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Report of immune monitoring of prostate cancer patients undergoing T-cell therapy using dendritic cells pulsed with HLA-A2-specific peptides from prostate-specific membrane antigen (PSMA)

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Follow-up evaluation of prostate cancer patients infused with autologous dendritic cells pulsed with PSMA peptides

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Evaluation of phase I/II clinical trials in prostate cancer with dendritic cells and PSMA peptides

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Infusion of dendritic cells pulsed with HLA-A2-specific prostate-specific membrane antigen peptides: a phase II prostate cancer vaccine trial involving patients with hormone-refractory metastatic disease

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Vaccination with mutant ras peptides and induction of T-cell responsiveness in pancreatic carcinoma patients carrying the corresponding RAS mutation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Ex vivo ras peptide vaccination in patients with advanced pancreatic cancer: results of a phase I/II study

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Cytotoxic CD4+ and CD8+ T lymphocytes, generated by mutant p21-ras (12Val) peptide vaccination of a patient, recognize 12Val-dependent nested epitopes present within the vaccine peptide and kill autologous tumour cells carrying this mutation

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

CD83+ blood dendritic cells as a vaccine for immunotherapy of metastatic renal-cell cancer

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Cellular and humoral immune responses in patients with metastatic renal cell carcinoma after vaccination with antigen pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Dendritic cell vaccines for cancer immunotherapy

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Vaccination of patients with B-cell lymphoma using autologous antigen-pulsed dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Letter: A new consistent chromosomal abnormality in chronic myelogenous leukaemia identified by quinacrine fluorescence and Giemsa staining

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Tyrosine kinase activity and transformation potency of bcr-abl oncogene products.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Chronic myelogenous leukemia in blast crisis. Analysis of 242 patients.

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Autografting in chronic myeloid leukaemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Interferon alfa-2a as compared with conventional chemotherapy for the treatment of chronic myeloid leukemia

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

T-cell immunity to the joining region of p210BCR-ABL protein

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Generation of dendritic cells expressing bcr-abl from CD34-positive chronic myeloid leukemia precursor cells

1 reference

https://api.crossref.org/works/10.1002%2F%28SICI%291097-0142%2819991215%2986%3A12%3C2674%3A%3AAID-CNCR12%3E3.0.CO%3B2-Z

21 January 2018

Identifiers

10.1002/(SICI)1097-0142(19991215)86:12<2674::AID-CNCR12>3.0.CO;2-Z

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:10594863%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73265616&oldid=1790260277"